Gerresheimer opens its first Development Center in China

Düsseldorf/Dongguan City (People’s Republic of China), October 22, 2014 – Gerresheimer AG, an internationally leading partner to the pharma and healthcare industry, has opened a new Development Center for medical plastic systems in Dongguan City, China. Now Gerresheimer has three such centers in Wackersdorf (Germany), Peachtree City (United States of America) and now in China.

“Our Development Centers are important USPs that allow us to offer our customers crucial added value. The new center in China ensures that we can optimally meet the growing demand in the Asian market. In future, we will have development operations in addition to local production operations and we’ll be collaborating closely with our customers in China,“ explained Andreas Schütte, the Gerresheimer Management Board member with responsibility for Plastics & Devices.

The team at the new Technical Competence Center (TCC) in China will be implementing and managing large-scale projects independently. Gerresheimer’s three Development Centers around the world prepare medical plastic systems such as insulin pens, inhalers, lancets and auto-injectors for industrialization. All crucial interdisciplinary functions up to a product’s series production stage are performed there. The local projects implemented at the Development Centers in collaboration with the other sites include series design, manufacturing equipment engineering, process development, project management, quality planning, tool making, automation technology, production initiation and pre-series production.

At its Dongguan City production facility, Gerresheimer has been manufacturing drug delivery devices such as inhalers and lancets for diabetes sufferers, and infusion products, since 2006.

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with 11,000 employees and manufacturing operations in the local markets, close to customers. It has over 40 production facilities in Europe, North and South America and Asia generating revenue in excess of EUR 1.3 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.

Contact us!
+49 211 61 81-00